Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus.

Yuh-Jyh Lin, Y. J. Tsai, Chien-Hsu Chen, J. S. Lin, Jing-Ming Wu, Chyi-Her Lin, T. F. Yeh

研究成果: Article同行評審

12 引文 斯高帕斯(Scopus)

摘要

Renal side effects and urinary prostaglandin were evaluated in 10 premature infants (Mean +/- SD: BW 1245 +/- 290 gm, GA 32 +/- 2.2 wks, Postnatal age 7.7 +/- 3.8 days) with significant PDA who were given one dose of indomethacin (0.3 mg/kg intravenously). There was a significant decrease in urinary output, osmolal and free water clearance after therapy. The fractional excretion of sodium, chloride, potassium, glomerular filtration rate and urinary prostaglandin E2 also decreased but were not statistically different from the baseline values. In infants who responded to indomethacin with ductus closure, their renal functions appeared to be preserved even though they had higher plasma indomethacin levels than the non-responders in whom significant changes in renal function were observed following indomethacin therapy. This observation suggested that the improved renal hemodynamics following the closure of the ductus may minimize or attenuate the renal side effects of indomethacin.

原文English
頁(從 - 到)104-107
頁數4
期刊Zhonghua Minguo xiao er ke yi xue hui za zhi [Journal]. Zhonghua Minguo xiao er ke yi xue hui
36
發行號2
出版狀態Published - 1995 一月 1

All Science Journal Classification (ASJC) codes

  • 兒科、圍產兒和兒童健康

指紋

深入研究「Renal effects and urinary excretion of prostaglandin following indomethacin therapy in premature infants with patent ductus arteriosus.」主題。共同形成了獨特的指紋。

引用此